Question 1

What is the catalog number for 10X Tris-EDTA (TE) Buffer (1X Tris-EDTA Buffer, pH7.5), Ultra Pure Grade, 100ml?

Accepted Answer

The catalog number for 10X Tris-EDTA (TE) Buffer (1X Tris-EDTA Buffer, pH7.5), Ultra Pure Grade, 100ml is PB1244-100ml.

Question 2

What sizes are available for 10X Tris-EDTA (TE) Buffer (1X Tris-EDTA Buffer, pH7.5), Ultra Pure Grade, 100ml?

Accepted Answer

10X Tris-EDTA (TE) Buffer (1X Tris-EDTA Buffer, pH7.5), Ultra Pure Grade, 100ml is available in the following size(s): 100 mL.

Question 3

Is 10X Tris-EDTA (TE) Buffer (1X Tris-EDTA Buffer, pH7.5), Ultra Pure Grade, 100ml in stock?

Accepted Answer

10X Tris-EDTA (TE) Buffer (1X Tris-EDTA Buffer, pH7.5), Ultra Pure Grade, 100ml is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 5

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

10X Tris-EDTA (TE) Buffer (1X Tris-EDTA Buffer, pH7.5), Ultra Pure Grade, 100ml

Product Specifications

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Nucleophosmin (Acute Myeloid Leukemia Marker) (rNPM1/1901), CF740 conjugate, 0.1mg/mL

CD45RO (T200/797), 0.2mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), 0.2mg/mL

Anti-SERCA2 ATPase/ATP2A2 Antibody Picoband®

EGFRvIII (Epidermal Growth Factor Receptor, Variant III) (GFR/2600R), CF568 conjugate, 0.1mg/mL

WT1 (Wilm's Tumor 1) (WT1/857 + 6F-H2), CF488A conjugate, 0.1mg/mL